Get the weekly note
ETFIQetfiq.com · independent ETF data

Data as of .

BBH vs BBP: which is really different?

BBH and BBP hold 22% of their weight in the same names, and BBP returned more over the year.

VanEck Biotech ETF and Virtus Biotech ETF.

60.4%BBH in the S&P 500
12.4%BBP in the S&P 500
+40.5%BBH total return, 1 year
+47.5%BBP total return, 1 year

ETFIQ Off-Index Score: BBH scores higher

How much of it is not the index it is sold as an alternative to?

BBH 61.7BBP 61.70.1, the lowest in this set91.8, the highest

A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed

BBH40% of its weight is outside the S&P 500 · 1 year to Sep 18, 2026
60%40%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 99% · top ten 72% of the fund · 24 holdings filed Sep 17, 2026 · Nasdaq-100: 47% in60%40%in the S&P 500outsideactive share 99% · top ten 72% of the fund
BBP88% of its weight is outside the S&P 500 · 1 year to Sep 18, 2026
12%88%inof its weight outside the S&P 500active share 99% · top ten 26% of the fund · 60 holdings filed Apr 30, 2026 · Nasdaq-100: 9% in12%88%inof its weight outside the S&P 500active share 99% · top ten 26% of the fund

22% of the two portfolios are the same securities at the same weight.

What they hold in common

By the books each fund has filed, BBH and BBP hold 22% of their money in the same securities at the same weight.

Positions BBH and BBP both hold, largest shared weight first
HoldingBBHBBP
Moderna Inc5.05%2.50%
United Therapeutics Corp2.12%1.85%
Amgen Inc15.03%1.75%
Biogen Inc2.71%1.74%
Gilead Sciences Inc13.81%1.74%
Biontech Se1.62%1.75%
Incyte Corp2.39%1.60%
Regeneron Pharmaceuticals Inc7.00%1.53%
Vertex Pharmaceuticals Inc8.32%1.52%
Beone Medicines Ltd2.75%1.48%
Neurocrine Biosciences Inc1.50%1.38%
Alnylam Pharmaceuticals Inc2.73%1.25%
Only in each
Only in BBHOnly in BBP
Natera Inc 4.97%IMMUNITYBIO INC 4.83%
Argenx Se 4.93%APELLIS PHARMACEUTICALS INC 2.60%
Iqvia Holdings Inc 4.61%KALVISTA PHARMACEUTICALS INC 2.53%
Revolution Medicines Inc 4.09%IOVANCE BIOTHERAPEUTICS INC 2.45%
Illumina Inc 3.68%MIRUM PHARMACEUTICALS INC 2.40%
Guardant Health Inc 3.15%AXSOME THERAPEUTICS INC 2.25%
Charles River Laboratories Internationa 1.48%KINIKSA PHARMACEUTICALS INTERNATIONAL PL 2.07%
Icon Plc 1.25%ROIVANT SCIENCES LTD 2.07%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Sep 18, 2026.

Performance, window by window

BBH and BBP over each window. Every figure is an ETFIQ calculation with distributions reinvested. Source: ETFIQ.
WindowTotal returnvs the S&P 500vs the Nasdaq-100
BBHBBPBBHBBPBBHBBP
3 months+24.8%+15.3%+22.5 pts+13.1 pts+27.3 pts+17.8 pts
6 months+29.0%+29.5%+11.0 pts+11.5 pts+4.8 pts+5.3 pts
1 year+40.5%+47.5%+23.9 pts+30.9 pts+18.7 pts+25.7 pts
3 years+48.9%+103.0%−29.5 pts+24.6 pts−49.3 pts+4.8 pts
Since launch+732.7%+304.4%−70.8 pts−56.6 pts−957.5 pts−371.1 pts
Open the live comparison on ETFIQ
BBH and BBP on the same fields, as of Sep 18, 2026. Source: ETFIQ.
BBH
VanEck Biotech ETF
Holds 24 stocks in biotech, 60% of its weight in S&P 500 companies
BBP
Virtus Biotech ETF
Holds 60 stocks in biotech, 12% of its weight in S&P 500 companies
IssuerVanEckVirtus
ThemeBiotechBiotech
In the S&P 50060.4%12.4%
Active share vs the S&P 50099.0%99.0%
In the Nasdaq-10047.2%8.9%
Holdings2460
Top ten, share of the fund72.4%25.7%
Expense ratio0.35%0.34%
Fee for the differing part0.35%0.34%
Total return, 1 year+40.5%+47.5%
vs the S&P 500+23.9 pts+30.9 pts
vs the Nasdaq-100+18.7 pts+25.7 pts
Below its high−4.0%−5.5%
Net assets$470m$59m

BBH in plain words

By weight, 60% of BBH's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 72% of the fund across 24 positions, as published by its issuer for Sep 18, 2026. Over the year to Sep 18, 2026 the fund returned +40.5% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 23.9 pts.

BBP in plain words

By weight, 12% of BBP's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 26% of the fund across 60 positions, as filed for Apr 30, 2026. Over the year to Sep 18, 2026 the fund returned +47.5% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 30.9 pts. It sits 5.5% below its all-time high of Aug 19, 2026.

Questions people ask

Do BBH and BBP hold the same stocks?
By their latest filings, 22% of their books are the same securities at the same weight, which is a meaningful overlap. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, BBH or BBP?
BBH has 60% of its weight in S&P 500 names and BBP has 12%, so BBH differs more from the index.
Which is cheaper, BBH or BBP?
BBH charges 0.35% a year and BBP charges 0.34%, so BBP is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

BBH against BBP, ETFIQ, data as of Sep 18, 2026. Every figure is calculated from a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, BBH against BBP, data as of Sep 18, 2026. https://etfiq.com/compare/themes/bbh-vs-bbp Free to use with attribution; the underlying files are at Open data.

How every figure is computed · Standards and sources